Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting: The Dutch Experience
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 06.11.2026
DOI: 10.1177/15569845261495044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, online erschienen am 06.11.2026. Verfasst von Roos de Jong und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Medical Center Utrecht, The Netherlands. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Hybrid coronary revascularization (HCR) is minimally invasive coronary artery bypass surgery in patients with multivessel disease. This study compared the clinical outcomes of robot-assisted HCR patients with those receiving conventional on-pump coronary artery bypass grafting (CABG) in the Netherlands.
Methods
We included 117 HCR and 2,160 CABG patients between January 2015 and December 2021. We performed a 1:3 propensity score matching (PSM) analysis. The primary outcome was the incidence of major adverse cardiac and cerebrovascular events (MACCE) at ≤30 days of follow-up. Secondary outcomes included red blood cell transfusions, length of stay, and the individual components of MACCE, which were mortality, perioperative myocardial infarction, revascularization of the target vessel (TVR), kidney failure, and in-hospital ischemic cerebrovascular accidents. Mortality and TVR at midterm follow-up were also included.
Results
After PSM, 115 HCR and 342 on-pump CABG patients were included. HCR patients underwent a mean ± standard deviation of 1 ± 0 distal anastomosis, whereas CABG patients had a mean of 3.6 ± 1.1 distal anastomoses. At ≤30 days of follow-up, no differences in MACCE (odds ratio [OR] = 1.27, 95% confidence interval [CI]: 0.48 to 2.88, P = 0.57) or in the individual secondary outcomes were found. HCR resulted in a shorter hospital stay (OR = 0.99, 95% CI: 0.99 to 1.0, P = 0.02). At a median of 35 months (interquartile range [IQR], 23 to 45) of follow-up in the HCR group and 34 months (IQR, 22 to 45) in the CABG group, all-cause mortality and TVR did not differ.
Conclusions
HCR provides excellent short-term and midterm outcomes, comparable to conventional CABG, while also offering faster recovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Medical Center Utrecht, The Netherlands.
- Netherlands Heart Registration, Utrecht, The Netherlands.
- Isala Clinics, Zwolle, The Netherlands.
- Maastricht University Medical Center, The Netherlands.
ORCID-Profile: Roos de Jong, Monica Gianoli
Zitieren
APA
Roos de Jong, Gianoli, M., Roefs, M., Singh, S., Segers, P., Voskuil, M., van der Harst, P., Suyker, W., & Jacob, K. (2026). Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting: The Dutch Experience. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. https://doi.org/10.1177/15569845261495044
Vancouver
Roos de Jong, Gianoli M, Roefs M, Singh S, Segers P, Voskuil M, et al. Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting: The Dutch Experience. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2026. doi:10.1177/15569845261495044
BibTeX
@article{RoosdeJong2026,
author = {Roos de Jong and Gianoli, Monica and Roefs, Maaike and Singh, Sandeep and Segers, Patrique and Voskuil, Michiel and van der Harst, Pim and Suyker, Willem and Jacob, Kirolos},
title = {Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting: The Dutch Experience},
journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
year = {2026},
doi = {10.1177/15569845261495044}
}
EUVIMED